• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Azithromycin Online Visit Our Pharmacy ↓

Click HERE To Buy Azithromycin Online ↓




  • Azithromycin Vs. Other Antibiotics: a Comparative Analysis

    Azithromycin: Unique Mechanism and Usage Overview


    Azithromycin is renowned for its distinctive mechanism of action, setting it apart in the world of antibiotics. Unlike many other antibiotics that target the bacterial cell wall, Azithromycin belongs to the macrolide class, which exerts its effect by inhibiting bacterial protein synthesis. This is achieved by binding to the 50S ribosomal subunit of susceptible microorganisms, effectively halting bacterial growth and replication.

    | Feature | Azithromycin | |------------------|--------------------------------------------| | Class | Macrolide | | Mechanism | Protein synthesis inhibition | | Target | 50S ribosomal subunit |

    This unique approach allows Azithromycin to be highly effective against a broad spectrum of bacteria, making it a popular choice for various infections. Its usage extends to conditions like respiratory infections, skin infections, and sexually transmitted diseases, providing versatility across different medical scenarios.



    Common Infections Treated: Azithromycin Versus Others



    When it comes to tackling infections, azithromycin stands out for its effectiveness against respiratory infections like pneumonia and bronchitis. Compared to penicillin, which is often prescribed for skin infections and dental abscesses, azithromycin is valued for its longer half-life, allowing less frequent dosing. While both azithromycin and amoxicillin are prescribed for ear infections, azithromycin is often chosen for individuals allergic to penicillin. On the other hand, azithromycin provides an advantageous option for treating sexually transmitted infections such as chlamydia, where its single-dose regimen is particularly appealing. This broad spectrum approach makes it a versatile choice, though each antibiotic has specific strengths depending on the infection type.



    Comparing Bacterial Resistance: Azithromycin and Its Rivals


    In the world of antibiotics, azithromycin stands out with its distinct mechanism of action that targets a broad spectrum of bacteria. However, the issue of bacterial resistance looms large across the board. Azithromycin is often favored for its ability to tackle resistant strains that have developed immunity to other antibiotics. Unlike some competitors, azithromycin accumulates effectively within cells, allowing it to combat intracellular pathogens with greater efficacy.

    Yet, the tide of resistance does not spare any antibiotic entirely. Over time, misuse and overuse have led to noticeable resistance even against azithromycin. This antibiotic's advantage lies in its slower resistance development, compared to some of its counterparts. Continuous research and responsible antibiotic stewardship are essential to preserve azithromycin's effectiveness, ensuring it remains a potent weapon in the battle against stubborn bacterial foes.

    Even as azithromycin's profile remains favorable, practitioners are wary of emerging resistance patterns. The key to maintaining its utility is balanced usage, combining it with other antibiotics judiciously when necessary. This strategic approach aims to mitigate resistance development and maintain the delicate equilibrium needed to combat bacterial infections effectively. Thus, azithromycin, with its benefits and challenges, remains a crucial player in the world of antibiotics.



    Azithromycin's Side Effects: How It Stacks up



    While widely celebrated for its efficacy in treating a range of bacterial infections, azithromycin is not without its side effects. Common side effects include nausea, diarrhea, and abdominal pain, generally mild and temporary. Compared to other antibiotics, azithromycin might offer an advantage due to its usually short, three-to-five-day course, reducing prolonged exposure and associated side effects. For some patients, gastrointestinal discomfort is minimal, tipping the balance in favor of azithromycin. Yet, like many antibiotics, it can occasionally cause more serious side effects, such as arrhythmias, especially in individuals with preexisting heart conditions. When pitted against drugs like erythromycin or clarithromycin, azithromycin often prevails as the more tolerable option for most patients, though monitoring by healthcare providers remains crucial to manage any adverse reactions effectively.



    Treatment Duration: Azithromycin in Contrast


    For many bacterial infections, azithromycin stands out due to its shorter treatment duration compared to other antibiotics. Known for its rapid action, a typical azithromycin course can last as short as three to five days, which is notably less than the seven to ten days required for many other antibiotics. This abbreviated timeline not only enhances patient compliance but also potentially reduces the risk of side effects, as patients are exposed to the antibiotic for a shorter period. Additionally, the drug's unique pharmacokinetic properties allow it to maintain effective levels in the body even after the last dose is taken.

    The extended half-life of azithromycin, which allows for daily dosing with a relatively short regimen, is particularly advantageous in outpatient settings. Patients often prefer this convenience, as it minimizes disruption to their daily schedules. Furthermore, shorter treatment durations have broader public health implications, potentially curbing the development of antibiotic resistance by limiting the period of bacterial exposure. Thus, azithromycin presents itself as an appealing option for both healthcare providers and patients seeking efficiency and effectiveness in antibacterial therapy.

    Antibiotic Typical Treatment Duration
    Azithromycin 3-5 days
    Other Antibiotics 7-10 days



    Patient Preference: Why Choose Azithromycin?


    For many, azithromycin is the preferred choice due to its once-daily dosing convenience, which simplifies adherence to treatment plans. This is especially beneficial for individuals with busy schedules or those who struggle with remembering medication regimens. Azithromycin's extended half-life allows for shorter courses of treatment compared to other antibiotics, enhancing patient compliance and reducing the potential for missed doses.

    Moreover, azithromycin is well-received for its minimal adverse effects compared to other common antibiotics, which can be harsh on the digestive system. Its tolerability makes it particularly appealing to pediatric and elderly patients, who are more sensitive to the gastrointestinal side effects typically associated with antibiotic therapy.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.